Medical Letter on the CDC & FDA provides the industry's most comprehensive coverage of the Centers for Disease Control and Prevention and the Food and Drug Administration, from outbreaks reporting to bioterror preparedness to drug approvals, labeling decisions and recalls.
Not only does Medical Letter on the CDC & FDA bring you more reports, but more coverage of CDC research and funding, and FDA regulatory actions.
Published weekly, each issue of Medical Letter on the CDC & FDA has more than 90 articles that cover the CDC and FDA from top to bottom, including the latest news, outbreaks and research concerning food safety, bacterial contaminants, prions and other zoonatic disease agents, SARS, avian influenza, HIV/AIDS, smallpox, hanta, ebola and other hemorrhagic viruses, homeland security regulations, drug regulation, fast-tracking and adverse reactions reports.
Additionally, the Medical Letter on the CDC & FDA covers similar news and developments from the World Health Organization, as well as public health agencies and U. S. CDC, FDA counterparts in Europe, Asia and the rest of the world.
NewsRx editors collect coverage from more than 4,000 peer-reviewed journals, dozens of industry meetings, medical news wires, pharmaceutical and biotech company internet sites, purchased databases, and press releases.
Each article, usually no more than 500 words, is written to be an information-heavy, concise report of the pertinent facts, together with full references and citations for original source material. You get a fast, user-friendly read that keeps you on top of all the important women's health-related developments for that week.
Medical Letter on the CDC & FDA is available in print or online at www.NewsRx.com. Email versions can be delivered directly to your desktop. Site licenses are also available for corporate use.
Combination print and email subscriptions are available, and all subscriptions come with online access to Medical Letter on the CDC & FDA's archives, which go back to 2000. See a sample issue here
The Medical Letter on the CDC & FDA has long been recognized as the most comprehensive and authoritative source for public health news and food and drug regulatory coverage. We stake our 20-plus year history as a healthcare publisher that it remains the best.
But don't take our word for it. Sign up for our six-week, no-risk free trial and see for yourself. Receive six issues of Medical Letter on the CDC & FDA, more than 540 articles, and see why it will become your indispensable tool for tracking CDC and FDA news and developments.
Subscribe now and we'll give you $300 off our regular subscription price. You get the power of the most comprehensive public health, food and drug regulation coverage in the industry at a great discount.
Start today, and eliminate all those hours you normally spend scanning dozens of periodicals, websites, and other information sources. We've done it for you; Medical Letter on the CDC & FDA has got you covered.
|
2009
